Company / Revenue per Share
Spyre Therapeutics, Inc. Revenue per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue per Share
-
FY2025
5-year range
$0.00 / $0.39
FY2021-FY2025
Trend
-
vs FY2024
Sector context
#147 of 154
Health Care
What the data says
Declined from $0.34 to $0.00 over the past 2 years.
Health Care sector context is included.
Revenue per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 5% in Health CareTop 95% of 154
▼
Key checks
Key Insights
- Peak revenue per share was recorded in FY2016.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 3.40 (safe zone, above 2.9 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Revenue per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.00 | - |
| FY2024 | $0.00 | -100.0% |
| FY2023 | $0.34 | - |
| FY2022 | $0.00 | -100.0% |
| FY2021 | $0.39 | +192.3% |
| FY2020 | $0.13 | -38.0% |
| FY2019 | $0.22 | -22.3% |
| FY2018 | $0.28 | -19.3% |
| FY2017 | $0.34 | -27.2% |
| FY2016 | $0.47 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026